These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 38029712)
1. The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas. Zhang X; Wang C; Shen D Pathol Res Pract; 2024 Jan; 253():154916. PubMed ID: 38029712 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and molecular characteristics of fumarate hydratase-deficient uterine smooth muscle tumors: a single-center study of 52 cases. Li H; Yang W; Tu X; Yu L; Huang D; Cheng Y; Chang B; Tang S; Ge H; Bao L; Zhou X; Bi R Hum Pathol; 2022 Aug; 126():136-145. PubMed ID: 35659509 [TBL] [Abstract][Full Text] [Related]
3. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients. Joseph NM; Solomon DA; Frizzell N; Rabban JT; Zaloudek C; Garg K Am J Surg Pathol; 2015 Nov; 39(11):1529-39. PubMed ID: 26457356 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome). Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337 [TBL] [Abstract][Full Text] [Related]
5. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC). Chan E; Rabban JT; Mak J; Zaloudek C; Garg K Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of somatic and germline mutations of Fumarate hydratase in uterine leiomyomas from young patients. Liu C; Dillon J; Beavis AL; Liu Y; Lombardo K; Fader AN; Hung CF; Wu TC; Vang R; Garcia JE; Xing D Histopathology; 2020 Feb; 76(3):354-365. PubMed ID: 31564060 [TBL] [Abstract][Full Text] [Related]
7. Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases. Bennett JA; Weigelt B; Chiang S; Selenica P; Chen YB; Bialik A; Bi R; Schultheis AM; Lim RS; Ng CKY; Morales-Oyarvide V; Young RH; Reuter VE; Soslow RA; Oliva E Mod Pathol; 2017 Oct; 30(10):1476-1488. PubMed ID: 28664937 [TBL] [Abstract][Full Text] [Related]
8. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816 [TBL] [Abstract][Full Text] [Related]
9. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287 [TBL] [Abstract][Full Text] [Related]
10. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience. Rabban JT; Chan E; Mak J; Zaloudek C; Garg K Am J Surg Pathol; 2019 May; 43(5):639-655. PubMed ID: 30741757 [TBL] [Abstract][Full Text] [Related]
11. [Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases]. Wang XX; Liu Y; Liu LC; Wang YX; Yang J; Hu AJ; Zhang B; Liu CR Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):574-579. PubMed ID: 37263921 [No Abstract] [Full Text] [Related]
12. Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach. Wyvekens N; Valtcheva N; Mischo A; Helmchen B; Hermanns T; Choschzick M; Hötker AM; Rauch A; Mühleisen B; Akhoundova D; Weber A; Moch H; Rupp NJ Genes Chromosomes Cancer; 2020 Nov; 59(11):611-619. PubMed ID: 32537760 [TBL] [Abstract][Full Text] [Related]
13. Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings. Harrison WJ; Andrici J; Maclean F; Madadi-Ghahan R; Farzin M; Sioson L; Toon CW; Clarkson A; Watson N; Pickett J; Field M; Crook A; Tucker K; Goodwin A; Anderson L; Srinivasan B; Grossmann P; Martinek P; Ondič O; Hes O; Trpkov K; Clifton-Bligh RJ; Dwight T; Gill AJ Am J Surg Pathol; 2016 May; 40(5):599-607. PubMed ID: 26574848 [TBL] [Abstract][Full Text] [Related]
14. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression. Anderson WJ; Tsai HK; Sholl LM; Hirsch MS Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731 [No Abstract] [Full Text] [Related]
15. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Chen YB; Brannon AR; Toubaji A; Dudas ME; Won HH; Al-Ahmadie HA; Fine SW; Gopalan A; Frizzell N; Voss MH; Russo P; Berger MF; Tickoo SK; Reuter VE Am J Surg Pathol; 2014 May; 38(5):627-37. PubMed ID: 24441663 [TBL] [Abstract][Full Text] [Related]
16. The Role of Morphology in Predicting Fumarate Hydratase-deficient Uterine Leiomyomas in Young Women. Bayram A; Bagbudar S; Sozen H; Onder S; Yavuz E Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):657-660. PubMed ID: 37751278 [TBL] [Abstract][Full Text] [Related]
17. Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma. Smith SC; Trpkov K; Chen YB; Mehra R; Sirohi D; Ohe C; Cani AK; Hovelson DH; Omata K; McHugh JB; Jochum W; Colecchia M; Amin M; Divatia MK; Hes O; Menon S; Werneck da Cunha I; Tripodi S; Brimo F; Gill AJ; Osunkoya AO; Magi-Galluzzi C; Sibony M; Williamson SR; Nesi G; Picken MM; Maclean F; Agaimy A; Cheng L; Epstein JI; Reuter VE; Tickoo SK; Tomlins SA; Amin MB Am J Surg Pathol; 2016 Nov; 40(11):1457-1472. PubMed ID: 27635946 [TBL] [Abstract][Full Text] [Related]
18. [A special uterine leiomyoma]. Brunet A; Verkarre V; Le Frère Belda MA Ann Pathol; 2020 Apr; 40(2):180-184. PubMed ID: 32192807 [TBL] [Abstract][Full Text] [Related]
19. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276 [TBL] [Abstract][Full Text] [Related]